Is AstraZeneca listed on the London Stock Exchange?

AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It had a market capitalisation of approximately £39.5 billion as of 23 December 2011, the 10th-largest of any company with a primary listing on the London Stock Exchange.

What happened to AstraZeneca's share price?

The pharmaceuticals firm experienced a rollercoaster day on the stock market. Its shares initially fell by 6 per cent, before rebounding after chief executive Pascal Soriot played down the impact the coronavirus has been having so far. It eventually closed down 4.3 per cent, or 326p, at 7300p.

Should you buy AstraZeneca shares on a 97 price-to-earnings (P/E) ratio?

Currently trading on a price-to-earnings (P/E) ratio of 97, the risk of you not making a decent return from its shares, at this price, is high. The AstraZeneca share price is at a historical high. Climbing steadily over the last 10 years it dropped in March in the stock market crash before exploding 53% to today’s peak price of 9,670p.